Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - TomoTherapy Inc | c56888exv32w2.htm |
10-K - FORM 10-K - TomoTherapy Inc | c56888e10vk.htm |
EX-23.2 - EX-23.2 - TomoTherapy Inc | c56888exv23w2.htm |
EX-31.2 - EX-31.2 - TomoTherapy Inc | c56888exv31w2.htm |
EX-23.1 - EX-23.1 - TomoTherapy Inc | c56888exv23w1.htm |
EX-31.1 - EX-31.1 - TomoTherapy Inc | c56888exv31w1.htm |
EX-10.33 - EX-10.33 - TomoTherapy Inc | c56888exv10w33.htm |
EX-10.45 - EX-10.45 - TomoTherapy Inc | c56888exv10w45.htm |
EX-10.38 - EX-10.38 - TomoTherapy Inc | c56888exv10w38.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report of TomoTherapy
Incorporated (the Company) on
Form 10-K
for the year ended December 31, 2009 (the
Report), I, Frederick A. Robertson, Chief
Executive Officer and President of the Company, hereby certify
pursuant to 18 U.S.C. § 1350, as adopted pursuant
to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934 (15 U.S.C. 78m or 78o(d)); and
2. The information contained in the Report fairly presents,
in all material respects, the financial condition and results of
operations of the Company.
Date: March 11, 2010
/s/ Frederick
A. Robertson
Chief Executive Officer and President
TomoTherapy Incorporated